Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pretreatment With Atropine to Reduce Exercise-triggered Ventricular Ectopy in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)

NCT02927223 is registered in ClinicalTrials.gov with Vanderbilt University as lead sponsor.

NCT NCT02927223
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02927223 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pretreatment With Atropine to Reduce Exercise-triggered Ventricular Ectopy in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
Lead sponsor
Vanderbilt University
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2016
Completion date
February 28, 2019
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

catecholaminergic polymorphic ventricular tachycardia